Drug repurposing—an emerging strategy in cancer therapeutics-Reference-Cited by-同舟云学术

Drug repurposing—an emerging strategy in cancer therapeutics

Published:2022-06-13 Issue:10 Volume:395 Page:1139-1158
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Turabi Khadija Shahab^ORCID,Deshmukh Ankita^ORCID,Paul Sayan^ORCID,Swami Dayanand^ORCID,Siddiqui Shafina^ORCID,Kumar Urwashi^ORCID,Naikar Shreelekha^ORCID,Devarajan Shine^ORCID,Basu Soumya^ORCID,Paul Manash K.^ORCID,Aich Jyotirmoi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00210-022-02263-x.pdf

Reference164 articles.

1. Abou-Issa H, Alshafie G (2004) Celecoxib: a novel treatment for lung cancer. Expert Rev Anticancer Ther 4:725–734. https://doi.org/10.1586/14737140.4.5.725

2. Adamo P, Ladomery MR (2016) The oncogene ERG: a key factor in prostate cancer. Oncogene 35:403–414. https://doi.org/10.1038/onc.2015.109

3. Aft R, Naughton M, Trinkaus K et al (2010) Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial. Lancet Oncol 11:421–428. https://doi.org/10.1016/S1470-2045(10)70054-1

4. Aftab BT, Dobromilskaya I, Liu JO, Rudin CM (2011) Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer. Cancer Res 71:6764–6772. https://doi.org/10.1158/0008-5472.CAN-11-0691

5. Ali R, Toh H-C, Chia W-K, Trial Investigators ASCOLT (2011) The utility of aspirin in dukes C and high risk dukes B colorectal cancer–the ASCOLT study: study protocol for a randomized controlled trial. Trials 12:261. https://doi.org/10.1186/1745-6215-12-261

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytotoxicity and cellular uptake capacity of a berberine-loaded nanogold/collagen drug delivery system in lung cancer;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-12

2. Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer;Journal of Experimental & Clinical Cancer Research;2024-08-20

3. Repurposing GnRH-A as a Near-Infrared Fluorescent Probe for Diagnosis and Surgical Navigation of Breast Cancer Tumors and Metastases;Journal of Medicinal Chemistry;2024-07-12

4. In Silico Drug Repurposing Against PSMB8 as a Potential Target for Acute Myeloid Leukemia Treatment;Molecular Biotechnology;2024-07-02

5. Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database;Current Drug Targets;2024-05